Turkey: Food, Drugs, Healthcare, Life Sciences

The legal framework governing dietary supplements in Turkey imposes significant compliance obligations on manufacturers to protect public health. These responsibilities span from pre-market technical documentation and conformity declarations to post-market product traceability and corrective action implementation, making systematic compliance policies essential for sustainable trade in today's food sector.

Life sciences companies in Turkey navigate a complex regulatory framework governing interactions with healthcare professionals, where promotional activities face strict oversight and compliance expectations continue to intensify. While pharmaceutical promotion remains limited to healthcare professionals with mandatory transparency reporting, medical device regulations show signs of convergence in enforcement practices.

Turkey's alternative reimbursement models enable innovative pharmaceuticals to be covered outside standard pricing rules, allowing the Social Security Institution to negotiate discount rates and budget caps. A new initiative launching in January 2027 will systematically produce real-world clinical data and pharmacoeconomic evaluations for named patient program products to strengthen evidence-based reimbursement decisions.